跳至主要内容
临床试验/ACTRN12612000386831
ACTRN12612000386831尚未招募2 期

Intranasal remifentanil for pain management during intubation and surfactant administration in premature newborns – a randomised double blind controlled pilot study of efficacy

Associate Professor Ian Wright0 个研究点目标入组 40 人开始时间: 2012年4月4日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
28 Weeks 至 44 Weeks(—)
性别
All

入选标准

  • Born at John Hunter Childrens Hospital and transferred to Neonatal Intensive Care Unit.
  • Require the INSURE procedure as part of their medical care.
  • Are 28–44 weeks post-conceptional age at the time of the procedure.

排除标准

  • Need for urgent intubation for resuscitation.
  • Major congenital anomalies likely to influence reliability of the primary outcome measure.
  • Severe neurological obtundation.
  • Current clinical seizures.
  • Concomitant muscle relaxant.

研究者

发起方
Associate Professor Ian Wright

相似试验